Compare MXCT & CLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MXCT | CLAR |
|---|---|---|
| Founded | 1999 | 1957 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 112.5M | 104.9M |
| IPO Year | 2021 | 1998 |
| Metric | MXCT | CLAR |
|---|---|---|
| Price | $1.07 | $3.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $5.50 | $4.08 |
| AVG Volume (30 Days) | ★ 1.0M | 96.3K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.80% |
| EPS Growth | N/A | ★ 11.68 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $33,026,000.00 | $228,000.00 |
| Revenue This Year | N/A | $5.27 |
| Revenue Next Year | $18.50 | $3.99 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.64 | $2.53 |
| 52 Week High | $2.19 | $4.03 |
| Indicator | MXCT | CLAR |
|---|---|---|
| Relative Strength Index (RSI) | 36.81 | 45.94 |
| Support Level | $0.97 | $3.08 |
| Resistance Level | $1.16 | $3.33 |
| Average True Range (ATR) | 0.08 | 0.09 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 7.00 | 8.20 |
MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.
Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and U.S.